1
|
Liamin M, Lara MP, Michelet O, Rouault M, Quintela JC, Le Bloch J. Olive juice dry extract containing hydroxytyrosol, as a nontoxic and safe substance: Results from pre-clinical studies and review of toxicological studies. Toxicol Rep 2023; 10:245-260. [PMID: 36852231 PMCID: PMC9958074 DOI: 10.1016/j.toxrep.2023.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 01/31/2023] [Accepted: 02/11/2023] [Indexed: 02/17/2023] Open
Abstract
Products derived from olives, such as the raw fruit and oils, are widely consumed due to their taste, and purported nutritional/health benefits. Phenolic compounds, especially hydroxytyrosol (HT), have been proposed as one of the key substances involved in these effects. An olive juice extract, standardized to contain 20% HT ("OE20HT"), was produced to investigate its health benefits. The aim of this study was to demonstrate the genotoxic safety of this ingredient based on in vitro Ames assay and in vitro micronucleus assay. Results indicated that OE20HT was not mutagenic at concentrations of up to 5000 µg/plate, with or without metabolic activation, and was neither aneugenic nor clastogenic after 3-hour exposure at concentrations of up to 60 µg/mL with or without metabolic activation, or after 24-hour exposure at concentrations of up to 40 µg/mL. To further substantiate the safety of OE20HT following ingestion without conducting additional animal studies, a comprehensive literature review was conducted. No safety concerns were identified based on acute or sub-chronic studies in animals, including reproductive and developmental studies. These results were supported by clinical studies demonstrating the absence of adverse effects after oral supplementation with olive extracts or HT. Based on in vitro data and the literature review, the OE20HT extract is therefore considered as safe for human consumption at doses up to 2.5 mg/kg body weight/day.
Collapse
Key Words
- 2AA, 2-aminoanthracene
- 9AA, 9-aminoacridine
- CBI, Centre for the Promotion of Imports from developing countries
- CP, cyclophosphamide monohydrate
- EFSA, European Food Safety Authority
- Food product
- Genotoxicity
- HT, hydroxytyrosol
- Hydroxytyrosol
- MF, mutation factor
- MMC, mitomycin C
- MMS, methyl-methanesulfonate
- Mutagenicity
- NDP, 4-nitro-1,2-phenylene-diamine
- NOAEL, no observed adverse effect level
- OE20HT, olive juice dry extract titrated 20% hydroxytyrosol
- OECD, Organization for Economic Co-operation and Development
- Olive fruit extract
- PD, population doubling
- RICC, relative increase in cell count
- RPD, relative population doubling
- SAZ, sodium azide
- Safety
Collapse
Affiliation(s)
- Marie Liamin
- Nutraveris, A Food Chain ID Company, 6 rue de la gare, 22000 Saint-Brieuc, France,Corresponding author.
| | - Maria Pilar Lara
- NATAC Biotech S.L., C/ Electrónica 7, 28923 Alcorcón, Madrid, Spain
| | - Olivier Michelet
- Nutraveris, A Food Chain ID Company, 6 rue de la gare, 22000 Saint-Brieuc, France
| | - Marie Rouault
- Nutraveris, A Food Chain ID Company, 6 rue de la gare, 22000 Saint-Brieuc, France
| | | | - Jérôme Le Bloch
- Nutraveris, A Food Chain ID Company, 6 rue de la gare, 22000 Saint-Brieuc, France
| |
Collapse
|
2
|
Nováková J, Vértesi A, Béres E, Petkov S, Niederberger KE, Van Gaver D, Hirka G, Balázs Z. Safety assessment of a novel thermostable phytase. Toxicol Rep 2020; 8:139-147. [PMID: 33437655 PMCID: PMC7787994 DOI: 10.1016/j.toxrep.2020.12.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2020] [Revised: 12/15/2020] [Accepted: 12/16/2020] [Indexed: 12/16/2022] Open
Abstract
The toxicity of Phytase TSP a new thermostable phytase was studied. No genotoxic or toxic effects were recorded for Phytase TSP. The NOAEL for the new Phytase TSP is 1000 mg/kg bw/d. The studies support the safety of Phytase TSP as an animal feed additive.
A novel 6-phytase (Phytase TSP, trade name OptiPhos® PLUS) with improved thermostability has been developed for use in animal feed. The safety of the new phytase was evaluated by testing for genotoxicity and subchronic toxicity. In in vitro and in vivo genotoxicity assays Phytase TSP concentrate was not mutagenic and did not induce biologically or statistically significant increases in the frequency of micronucleated polychromatic erythrocytes. In a subchronic toxicity study, male and female rats administered 100, 500 or 1000 mg/kg body weight/day of Phytase TSP concentrate via oral gavage for 90 days had no mortalities, and no treatment-related effects on body weight, food consumption, clinical observations or ophthalmology. Furthermore, there were no changes in haematology, clinical chemistry, urinalysis, gross pathology, organ weights or histopathology that could be attributed to the test article. Several endpoints exhibited statistically significant effects, but none was dose-related or considered to be of toxicological relevance. Based on these results, Phytase TSP concentrate (OptiPhos® PLUS) was not genotoxic and the No Observed Adverse Effect Level (NOAEL) for male and female rats was 1000 mg/kg body weight/day.
Collapse
Key Words
- 2AA, 2-aminoanthracene
- 6-phytase
- 9AA, 9-aminoacridine
- AAFCO, Association of American Feed Control Officials
- ANOVA, analysis of variance
- DMSO, Dimethyl sulfoxide
- GLP, Good Laboratory Practice
- Genotoxicity
- IACUC, Institutional Animal Care and Use Committee
- MMS, methylmethanesulfonate
- MPCE, polychromatic erythrocytes with micronuclei
- NOAEL, no observed adverse effect level
- NPD, 4-nitro-12-phenylenediamine
- OECD, Organisation for Economic Co-Operation
- OptiPhos PLUS
- PCE, polychromatic erythrocyte
- Phytase TSP
- SAZ, sodium azide
- Subchronic toxicity
- Thermostable phytase
- Toxicity
- bw, body weight
Collapse
Affiliation(s)
- Jana Nováková
- MediTox s.r.o., Pod Zamkem 279, 281 25, Konarovice, Czech Republic
| | - Adél Vértesi
- Toxi-COOP Toxicological Research Center ZRT., Balatonfüred, Arácsi út 97, 8230, Hungary
| | - Erzsébet Béres
- Toxi-COOP Toxicological Research Center ZRT., Balatonfüred, Arácsi út 97, 8230, Hungary
| | - Spas Petkov
- Huvepharma EOOD, 39 Petar Rakov Street, 4550, Peshtera, Bulgaria
| | | | - Davy Van Gaver
- Huvepharma N.V., Uitbreidingstraat 80, 2600, Antwerp, Belgium
| | - Gábor Hirka
- Toxi-COOP Toxicological Research Center ZRT., Balatonfüred, Arácsi út 97, 8230, Hungary
| | - Zoltán Balázs
- Leveret GmbH, Aberenrain 30, 6340, Baar, Switzerland
| |
Collapse
|
3
|
Yoshino S, Awa R, Ohto N, Miyake Y, Kuwahara H. Toxicological evaluation of standardized Kaempferia parviflora extract: Sub-chronic and mutagenicity studies. Toxicol Rep 2019; 6:544-549. [PMID: 31249788 PMCID: PMC6587015 DOI: 10.1016/j.toxrep.2019.06.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Revised: 06/04/2019] [Accepted: 06/06/2019] [Indexed: 11/28/2022] Open
Abstract
Kaempferia parviflora (KP), also known as Krachai-dam in Thailand, belongs to the family Zingiberaceae and has been used traditionally to improve blood flow and treat inflammatory, allergic, and gastrointestinal disorders. The objective of this study was to investigate the safety profile of a standardized hydroalcoholic KP rhizome extract via mutagenicity and sub-chronic toxicity evaluations using in vitro and in vivo techniques. The in vitro mutagenicity of KP extract was assessed via reverse mutation tests using Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2 uvrA. The sub-chronic toxicity profile was evaluated after daily oral administration of KP extract to Sprague-Dawley rats for 90 days. General toxicological parameters were monitored weekly. After the treatment period, blood was collected for hematological and biochemical analyses and certain organs were removed for macroscopic and histopathological analyses. Reverse mutation tests revealed that KP extract did not induce gene mutations at any of the concentrations tested. In the sub-chronic toxicity test, a few changes were observed, including increased salivation in the animals administered high-dose KP extract (249 mg/kg body weight (bw)/day). No toxicologically relevant changes were observed in the biochemical analysis. Sub-chronic administration of KP extract increased platelet levels in animals administered low-dose KP extract (25 mg/kg bw/day). However, the hematological and biochemical parameters remained within normal physiological ranges for the animal species. No toxicological changes were observed in the macroscopic and histopathological analyses performed in this study. These results demonstrate that KP extract is not genotoxic and that 90-day oral administration of the doses tested did not result in toxicity. Therefore, KP extract has a high safety margin for daily use.
Collapse
Affiliation(s)
- Susumu Yoshino
- Research Center, Maruzen Pharmaceuticals Co., Ltd., 1089-8 Sagata, Shinnichi, Fukuyama, Hiroshima, 729-3102, Japan
| | - Riyo Awa
- Research Center, Maruzen Pharmaceuticals Co., Ltd., 1089-8 Sagata, Shinnichi, Fukuyama, Hiroshima, 729-3102, Japan
| | - Nobuaki Ohto
- Research Center, Maruzen Pharmaceuticals Co., Ltd., 1089-8 Sagata, Shinnichi, Fukuyama, Hiroshima, 729-3102, Japan
| | - Yasuo Miyake
- Research Center, Maruzen Pharmaceuticals Co., Ltd., 1089-8 Sagata, Shinnichi, Fukuyama, Hiroshima, 729-3102, Japan
| | - Hiroshige Kuwahara
- Research Center, Maruzen Pharmaceuticals Co., Ltd., 1089-8 Sagata, Shinnichi, Fukuyama, Hiroshima, 729-3102, Japan
| |
Collapse
|
4
|
Hobbs CA, Saigo K, Koyanagi M, Hayashi SM. Magnesium stearate, a widely-used food additive, exhibits a lack of in vitro and in vivo genotoxic potential. Toxicol Rep 2017; 4:554-559. [PMID: 29090120 PMCID: PMC5655391 DOI: 10.1016/j.toxrep.2017.10.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2017] [Revised: 09/28/2017] [Accepted: 10/13/2017] [Indexed: 11/19/2022] Open
Abstract
Magnesium stearate is widely used in the production of dietary supplement and pharmaceutical tablets, capsules and powders as well as many food products, including a variety of confectionery, spices and baking ingredients. Although considered to have a safe toxicity profile, there is no available information regarding its potential to induce genetic toxicity. To aid safety assessment efforts, magnesium sulfate was evaluated in a battery of tests including a bacterial reverse mutation assay, an in vitro chromosome aberration assay, and an in vivo erythrocyte micronucleus assay. Magnesium stearate did not produce a positive response in any of the five bacterial strains tested, in the absence or presence of metabolic activation. Similarly, exposure to magnesium stearate did not lead to chromosomal aberrations in CHL/IU Chinese hamster lung fibroblasts, with or without metabolic activation, or induce micronuclei in the bone marrow of male CD-1 mice. These studies have been used by the Japanese government and the Joint FAO/WHO Expert Committee on Food Additives in their respective safety assessments of magnesium stearate. These data indicate a lack of genotoxic risk posed by magnesium stearate consumed at current estimated dietary exposures. However, health effects of cumulative exposure to magnesium via multiple sources present in food additives may be of concern and warrant further evaluation.
Collapse
Key Words
- 2AA, 2-aminoanthracene
- 9AA, 9-aminoacridine hydrochloride monohydrate
- ADI, acceptable daily intake
- AF-2, 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide
- DMSO, dimethyl sulfoxide
- DNA damage
- Dietary supplement
- EFSA, European Food Safety Authority
- ENNG, N-ethyl-N'-nitro-N-nitrosoguanidine
- FAO, Food and Agriculture Organization of the United Nations
- FDA, U.S. Food and Drug Administration
- Food additive
- GLP, Good Laboratory Practice
- Genotoxicity
- JECFA, Joint FAO/WHO Expert Committee on Food Additives
- Joint FAO/WHO Expert Committee on Food Additives (JECFA)
- MMC, mitomycin C
- MN, micronucleus or micronuclei
- MN-PCE, micronucleated polychromatic erythrocyte(s)
- Magnesium stearate
- OECD, Organization for Economic Cooperation and Development
- PCE, polychromatic erythrocyte(s)
- WHO, World Health Organization
Collapse
Affiliation(s)
- Cheryl A. Hobbs
- Toxicology Program, Integrated Laboratory Systems, Inc., PO Box 13501, Research Triangle Park, NC 27709, USA
| | - Kazuhiko Saigo
- Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd., 2438 Miyanoura-cho, Kagoshima-City, Kagoshima 891-1394, Japan
| | - Mihoko Koyanagi
- Global Scientific and Regulatory Affairs, San-Ei Gen F.F.I., Inc., 1-1-11 Sanwa-cho, Toyonaka, Osaka 561-8588, Japan
| | - Shim-mo Hayashi
- Global Scientific and Regulatory Affairs, San-Ei Gen F.F.I., Inc., 1-1-11 Sanwa-cho, Toyonaka, Osaka 561-8588, Japan
| |
Collapse
|
5
|
Honda H, Fujita Y, Hayashi A, Ikeda N, Ito Y, Morita O. Genotoxicity evaluation of alpha-linolenic acid-diacylglycerol oil. Toxicol Rep 2016; 3:716-722. [PMID: 28959597 PMCID: PMC5616014 DOI: 10.1016/j.toxrep.2016.08.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2016] [Revised: 08/08/2016] [Accepted: 08/08/2016] [Indexed: 11/07/2022] Open
Abstract
We evaluated the genotoxicity of ALA-DAG oil using standard tests. Bacterial reverse mutation and in vitro/in vivo micronucleus tests were conducted. No genotoxicity was observed under the testing conditions.
The alpha-linolenic acid (ALA)-diacylglycerol (DAG) oil is an edible oil enriched with DAG (>80%) and ALA (>50%). Although DAG oil, which mainly consists of oleic and linoleic acids has no genotoxic concerns, the fatty acid composition could affect the chemical property of DAG. Therefore, the purpose of this study was to evaluate the genotoxicity of ALA-DAG oil using standard genotoxicity tests in accordance with the OECD guidelines. ALA-DAG oil showed negative results in the bacterial reverse mutation test (Ames test) and in vitro micronucleus test in cultured Chinese hamster lung cells with and without metabolic activation, and in the in vivo bone marrow micronucleus test in mice. Our results did not show any genotoxicity, suggesting that the fatty acid composition had no deleterious effects. We conclude that ALA-DAG oil had no genotoxicity concerns under the testing conditions.
Collapse
Key Words
- 2AA, 2-aminoanthracene
- 9AA, 9-aminoacridine hydrochloride hydrate
- AF-2, 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide
- ALA, alpha-linolenic acid
- Alpha-linolenic acid
- Alpha-linolenic acid-rich diacylglycerol
- B(a)P, benzo(a)pyrene
- CLC, Colchicine
- CP, cyclophosphamide
- DAG, diacylglycerol
- DMSO, dimethyl sulfoxide
- Diacylglycerol
- Fatty acid composition
- Genotoxicity
- ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
- LA, linolenic acid
- MMC, mitomycin C
- MNPCE, micronucleated polychromatic erythrocyte
- NCE, normochromatic erythrocyte
- NaN3, sodium azide
- TAG, triacylglycerol
Collapse
Affiliation(s)
- Hiroshi Honda
- R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan
| | - Yurika Fujita
- R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan
| | - Aya Hayashi
- Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories Ltd., 2438 Miyanoura, Yoshida, Kagoshima 891-1394, Japan
| | - Naohiro Ikeda
- R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan
| | - Yuichi Ito
- R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan
| | - Osamu Morita
- R&D Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan
| |
Collapse
|